Jill A. Howe - Chief Financial Officer at Lineage Cell Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Financial Officer
Stock Symbol
LCTX on NYSE
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

Jill A. Howe - trading volume in the past year for Lineage Cell Therapeutics, Inc.

Holdings reported by Jill A. Howe for Lineage Cell Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Shares 10.5K $9.35K $0.89 Aug 16, 2024 Direct
Employee Stock Option (Right to Buy) 650K Mar 7, 2024 Direct Common Shares

Transactions reported by Jill A. Howe for Lineage Cell Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.